Related Experiment Video
Updated: Jun 16, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Treatment of Tuberculous Pleurisy With Contezolid in a Child With Glucose-6-Phosphate Dehydrogenase Deficiency: The
Shaolan Shi1, Binbin Feng, Dan Li
1From the Department of Tuberculosis Medicine Three wards, Shandong Public Health Clinical Center, Jinan, China.
Insights
This study reports the first pediatric case of tuberculous pleurisy and glucose-6-phosphate dehydrogenase deficiency treated with contezolid. The patient showed a positive response without adverse events, suggesting contezolid as a potential treatment option.
Area of Science:
- Pediatric infectious diseases
- Pharmacology
- Genetics
Background:
- Tuberculous pleurisy is a significant global health concern, particularly in pediatric populations.
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency presents challenges in drug selection due to potential hemolytic anemia.
- Limited treatment options exist for complicated pediatric tuberculous pleurisy, especially with co-existing genetic conditions.
Abstract:
This is the first reported case of a pediatric patient with tuberculous pleurisy and glucose-6-phosphate dehydrogenase deficiency treated with contezolid concomitantly with other antituberculous drugs. The patient responded well to treatment, and no adverse events were observed. These findings suggest that contezolid may be a potential therapeutic option for tuberculous pleurisy in children and adolescents with glucose-6-phosphate dehydrogenase deficiency.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

